2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$2.57+$0.05 (+2.02%)
Price as of Oct 02, 2026 5:56 PM EDT- $387.0MMarket Cap
- -35.22%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$2.57+$0.05 (+2.02%)
EDIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.52 | ||
Change | -$0.05 (-1.95%) | ||
Open | $2.61 | ||
High | $2.62 | ||
Low | $2.52 | ||
Previous Close | $2.57 | ||
Volume | 1,544,253 | ||
30-Day Average Volume | 2,951,998 | ||
1-Week Change | -8.36% | ||
1-Month Change | -17.92% | ||
1-Year Change | -35.22% | ||
3-Year Change | -67.69% | ||
5-Year Change | -93.69% | ||
Fundamentals | |||
Shares Outstanding | 153.6M | ||
Total Assets | $237.4M | ||
Market Cap | $387.0M | ||
Enterprise Value | $260.9M | ||
Period: QTR TTM FY | |||
Revenue | $11.9M | ||
Net Income | -$18.2M | ||
Free Cash Flow | -$29.7M | ||
EBIT | -$17.2M | ||
EBITDA | -$16.8M | ||
Net Working Capital | $149.6M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 4 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue